DocMorris End Period Cash Flow from 2010 to 2026

DOCM Stock   5.13  0.02  0.39%   
DocMorris End Period Cash Flow yearly trend continues to be fairly stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2026. During the period from 2010 to 2026, DocMorris End Period Cash Flow regression line of quarterly data had mean square error of 7266.8 T and geometric mean of  65,253,815. View All Fundamentals
 
End Period Cash Flow  
First Reported
2009-12-31
Previous Quarter
95.4 M
Current Value
150.3 M
Quarterly Volatility
91 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check DocMorris financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DocMorris' main balance sheet or income statement drivers, such as Depreciation And Amortization of 55 M, Interest Expense of 24.1 M or Selling General Administrative of 31.1 M, as well as many indicators such as Price To Sales Ratio of 0.25, Dividend Yield of 0.0819 or PTB Ratio of 0.76. DocMorris financial statements analysis is a perfect complement when working with DocMorris Valuation or Volatility modules.
  
This module can also supplement various DocMorris Technical models . Check out the analysis of DocMorris Correlation against competitors.
The evolution of End Period Cash Flow for DocMorris AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how DocMorris compares to historical norms and industry peers.

Latest DocMorris' End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of DocMorris AG over the last few years. It is DocMorris' End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DocMorris' overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

DocMorris End Period Cash Flow Regression Statistics

Arithmetic Mean105,811,360
Geometric Mean65,253,815
Coefficient Of Variation89.36
Mean Deviation73,662,028
Median95,371,000
Standard Deviation94,551,882
Sample Variance8940.1T
Range293.2M
R-Value0.49
Mean Square Error7266.8T
R-Squared0.24
Significance0.05
Slope9,133,927
Total Sum of Squares143040.9T

DocMorris End Period Cash Flow History

2026115.4 M
2025109.7 M
202495.4 M
202354 M
2022126 M
2021277.7 M
2020300.6 M

About DocMorris Financial Statements

DocMorris investors use historical fundamental indicators, such as DocMorris' End Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in DocMorris. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow109.7 M115.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for DocMorris Stock Analysis

When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.